[nugget]

You’d follow an asymptomatic false positive blood test with at worst a whole body MRI and at best a targeted imaging study (if the blood markers are specific). You’d have a further false positive rate from that but it drops off quickly. The cost is manageable. And some of that cost is offset because you catch cancers earlier when they are less expensive to treat. A substantial cost savings will come through first line analysis of imaging by AI, to highlight images for radiologists to focus on.